Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 3
1952 2
1953 3
1954 1
1957 2
1958 2
1959 3
1961 1
1962 2
1963 2
1964 2
1965 3
1966 3
1967 1
1968 2
1969 4
1970 2
1971 3
1973 3
1974 4
1975 3
1976 10
1977 10
1978 12
1979 4
1980 5
1981 9
1982 6
1983 7
1984 8
1985 11
1986 18
1987 10
1988 21
1989 21
1990 17
1991 20
1992 20
1993 15
1994 14
1995 10
1996 7
1997 12
1998 10
1999 14
2000 22
2001 24
2002 16
2003 21
2004 27
2005 24
2006 34
2007 37
2008 25
2009 30
2010 24
2011 20
2012 30
2013 33
2014 26
2015 33
2016 39
2017 38
2018 37
2019 42
2020 30
2021 39
2022 37
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

957 results
Results by year
Filters applied: . Clear all
Page 1
ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer.
Hashimoto S, Furukawa S, Hashimoto A, Tsutaho A, Fukao A, Sakamura Y, Parajuli G, Onodera Y, Otsuka Y, Handa H, Oikawa T, Hata S, Nishikawa Y, Mizukami Y, Kodama Y, Murakami M, Fujiwara T, Hirano S, Sabe H. Hashimoto S, et al. Among authors: oikawa t. Proc Natl Acad Sci U S A. 2019 Aug 27;116(35):17450-17459. doi: 10.1073/pnas.1901765116. Epub 2019 Aug 9. Proc Natl Acad Sci U S A. 2019. PMID: 31399545 Free PMC article.
Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles.
Sugo T, Terada M, Oikawa T, Miyata K, Nishimura S, Kenjo E, Ogasawara-Shimizu M, Makita Y, Imaichi S, Murata S, Otake K, Kikuchi K, Teratani M, Masuda Y, Kamei T, Takagahara S, Ikeda S, Ohtaki T, Matsumoto H. Sugo T, et al. Among authors: oikawa t. J Control Release. 2016 Sep 10;237:1-13. doi: 10.1016/j.jconrel.2016.06.036. Epub 2016 Jun 29. J Control Release. 2016. PMID: 27369865
Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study.
Tsuji K, Sakata Y, Nochioka K, Miura M, Yamauchi T, Onose T, Abe R, Oikawa T, Kasahara S, Sato M, Shiroto T, Takahashi J, Miyata S, Shimokawa H; CHART-2 Investigators. Tsuji K, et al. Among authors: oikawa t. Eur J Heart Fail. 2017 Oct;19(10):1258-1269. doi: 10.1002/ejhf.807. Epub 2017 Mar 31. Eur J Heart Fail. 2017. PMID: 28370829 Free article.
Should Pre-hypertension Be Treated?
Kanegae H, Oikawa T, Kario K. Kanegae H, et al. Among authors: oikawa t. Curr Hypertens Rep. 2017 Oct 18;19(11):91. doi: 10.1007/s11906-017-0789-z. Curr Hypertens Rep. 2017. PMID: 29046988 Review.
Kyoto classification risk scoring system and endoscopic grading of gastric intestinal metaplasia for gastric cancer: Multicenter observation study in Japan.
Kawamura M, Uedo N, Koike T, Kanesaka T, Hatta W, Ogata Y, Oikawa T, Iwai W, Yokosawa S, Honda J, Asonuma S, Okata H, Ohyauchi M, Ito H, Abe Y, Ara N, Kayaba S, Shinkai H, Shimokawa T. Kawamura M, et al. Among authors: oikawa t. Dig Endosc. 2022 Mar;34(3):508-516. doi: 10.1111/den.14114. Epub 2021 Sep 16. Dig Endosc. 2022. PMID: 34415621
957 results